Public health groups and patent lawyers in India have raised concerns about proposed amendments to the country's patent rules. They argue that the changes could weaken public health safeguards and hinder access to affordable generic medicines. The amendments could impact provisions such as pre-grant opposition and transparency in the patent system.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/Rq6bulL
